BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $139,000 | -19.2% | 22,604 | -2.8% | 0.00% | 0.0% |
| Q2 2018 | $172,000 | +38.7% | 23,263 | +23.4% | 0.00% | 0.0% |
| Q1 2018 | $124,000 | -33.0% | 18,850 | -14.1% | 0.00% | 0.0% |
| Q4 2017 | $185,000 | -22.3% | 21,949 | +6.6% | 0.00% | -50.0% |
| Q3 2017 | $238,000 | +4.8% | 20,584 | +6.1% | 0.00% | 0.0% |
| Q2 2017 | $227,000 | +9.1% | 19,393 | +14.9% | 0.00% | 0.0% |
| Q1 2017 | $208,000 | -28.3% | 16,880 | -20.7% | 0.00% | -33.3% |
| Q4 2016 | $290,000 | -23.9% | 21,275 | +11.2% | 0.00% | -40.0% |
| Q3 2016 | $381,000 | +29.6% | 19,124 | -15.6% | 0.01% | +25.0% |
| Q2 2016 | $294,000 | +53.1% | 22,654 | +10.6% | 0.00% | +33.3% |
| Q1 2016 | $192,000 | -57.9% | 20,491 | -9.0% | 0.00% | -50.0% |
| Q4 2015 | $456,000 | – | 22,515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,026,402 | $21,832,000 | 2.20% |
| Avoro Capital Advisors LLC | 262,515 | $5,584,000 | 1.54% |
| Lamond Capital Partners LLC | 68,780 | $1,463,000 | 1.48% |
| Green Owl Capital Management, LLC | 90,000 | $1,914,000 | 1.36% |
| Baker Brothers Advisors | 4,190,594 | $89,134,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,514 | $4,924,000 | 0.48% |
| Redmile Group, LLC | 238,121 | $5,065,000 | 0.42% |
| Highlander Capital Management, LLC | 19,250 | $409,000 | 0.37% |
| Spark Investment Management LLC | 110,500 | $2,350,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 145,380 | $3,092,000 | 0.24% |